Eliem Therapeutics Inc (NASDAQ: ELYM)
$7.04
+0.0500 ( +0.71% ) 255.5K
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).
Market Data
Open
$7.04
Previous close
$6.99
Volume
255.5K
Market cap
$471.51M
Day range
$6.93 - $7.55
52 week range
$2.35 - $11.55
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
3 | Insider transactions | 2 | Jun 27, 2024 |
3 | Insider transactions | 2 | Jun 27, 2024 |
8-k | 8K-related | 27 | Jun 27, 2024 |
8-k | 8K-related | 13 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
8-k | 8K-related | 15 | Jun 12, 2024 |
ars | Annual reports | 1 | Jun 04, 2024 |